International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring

Abstract The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and summarizes recent advances in the technology behind glucose monitoring, and its role in glucose-responsive integrated technology that is feasible with the use of automated insulin delivery (AID) systems in children and adolescents.

• Publication year

  2025

• Venue

  Hormone Research in Paediatrics

• Publication date

  2025-01-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000543156PMID 39884260PMCID 11854985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Glucose Management Indicator: Time to Change Course?

  2024influential reference
• Comparing the glycaemic outcomes between real‐time continuous glucose monitoring (rt‐CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials

  2024cited by this paper
• Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems

  2024cited by this paper
• ISPAD Clinical Practice Consensus Guidelines 2024: Type 2 Diabetes in Children and Adolescents

  2024cited by this paper
• International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets

  2024cited by this paper
• ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes

  2024cited by this paper
• Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems

  2024influential reference
• Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial

  2023cited by this paper
• High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes.

  2023influential reference
• Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016–2022) from the T1D Exchange Quality Improvement Collaborative

  2023cited by this paper
• The Effect of Do-It-Yourself Real-Time Continuous Glucose Monitoring on Glycemic Variables and Participant-Reported Outcomes in Adults With Type 1 Diabetes: A Randomized Crossover Trial

  2023cited by this paper
• OGTT metrics surpass continuous glucose monitoring data for T1D prediction in multiple-autoantibody-positive individuals.

  2023cited by this paper
• Patient experiences of continuous glucose monitoring and sensor‐augmented insulin pump therapy for diabetes: A systematic review of qualitative studies

  2023cited by this paper
• Continuous Glucose Monitoring versus Standard of Care in Adolescents With Type 2 Diabetes: A Pilot Randomized Cross-Over Trial

  2023cited by this paper
• Short-term use of CGM in youth onset type 2 diabetes is associated with behavioral modifications

  2023cited by this paper
• Predicting Immunological Risk for Stage 1 and Stage 2 Diabetes Using a 1-Week CGM Home Test, Nocturnal Glucose Increments, and Standardized Liquid Mixed Meal Breakfasts, with Classification Enhanced by Machine Learning

  2023cited by this paper
• Glycemic Control by Treatment Modalities: National Registry-Based Population Data in Children and Adolescents with Type 1 Diabetes

  2023cited by this paper
• Twelve‐month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes

  2023cited by this paper
• Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study.

  2023cited by this paper
• Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System

  2023cited by this paper
• School Nurse Confidence with Diabetes Devices in Relation to Diabetes Knowledge and Prior Training: A Study of Convergent Validity

  2023cited by this paper
• Performance Assessment of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes

  2023cited by this paper
• Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes

  2023cited by this paper
• Recent Rates of Substance Use Among Adolescents and Young Adults with Type 1 Diabetes in the USA

  2023cited by this paper
• CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.

  2023cited by this paper
• Safety and user experience with off-label use of a flash glucose monitor (FreeStyle Libre® 1) among very young children with type 1 diabetes mellitus

  2023cited by this paper
• Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.

  2023cited by this paper
• Barriers and Facilitators to Uptake of Continuous Glucose Monitoring for Management of Type 2 Diabetes Mellitus in Youth

  2023cited by this paper
• Glycemic and Psychosocial Correlates of Continuous Glucose Monitor Use Among Adolescents With Type 1 Diabetes

  2023cited by this paper
• First International Survey on Diabetes Providers’ Assessment of Skin Reactions in Youth With Type 1 Diabetes Using Technological Devices

  2023cited by this paper
• Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: A systematic review and network meta‐analysis of randomized controlled trials

  2023cited by this paper
• Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes

  2022cited by this paper
• CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review

  2022cited by this paper
• ISPAD Clinical Practice Consensus Guidelines 2022: Management of the child, adolescent, and young adult with diabetes in limited resource settings

  2022cited by this paper
• ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in children and adolescents with diabetes

  2022cited by this paper
• Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.

  2022cited by this paper
• Monthly video consultation for children and adolescents with type 1 diabetes mellitus during the COVID-19 pandemic

  2022cited by this paper
• Effect of nationwide reimbursement of real-time continuous glucose monitoring on HbA1c, hypoglycemia and quality of life in a pediatric type 1 diabetes population: The RESCUE-pediatrics study

  2022cited by this paper
• Improved CGM Glucometrics and More Visits in Pediatric Type 1 Diabetes using Telemedicine During 1 Year of COVID-19.

  2022cited by this paper
• Comparison Between Continuous Versus Flash Glucose Monitoring in Children, Adolescents, and Young Adults with Type 1 Diabetes: An 8-Week Prospective Randomized Trial

  2022cited by this paper
• Use of Continuous Glucose Monitors by People Without Diabetes: An Idea Whose Time Has Come?

  2022cited by this paper
• Monitoring of paediatric type 1 diabetes

  2022cited by this paper
• Early Initiation of Intermittently Scanned Continuous Glucose Monitoring in a Pediatric Population With Type 1 Diabetes: A Real World Study

  2022cited by this paper
• An effective and cost‐saving structured education program teaching dynamic glucose management strategies to a socio‐economically deprived cohort with type 1 diabetes in a VIRTUAL setting

  2022cited by this paper
• Exploring Minimally Invasive Approach to Define Stages of Type 1 Diabetes Remotely

  2022cited by this paper
• Parents' views about healthcare professionals having real‐time remote access to their young child's diabetes data: Qualitative study

  2022cited by this paper
• Laboratory Protocol and Pilot Results for Dynamic Interference Testing of Continuous Glucose Monitoring Sensors

  2022cited by this paper
• Effect of Ethanol Consumption on the Accuracy of a Glucose Oxidase-Based Subcutaneous Glucose Sensor in Subjects with Type 1 Diabetes

  2022cited by this paper
• Diabetes Specialists Value Continuous Glucose Monitoring Despite Challenges in Prescribing and Data Review Process

  2022cited by this paper
• Recent Advancement in Biofluid-Based Glucose Sensors Using Invasive, Minimally Invasive, and Non-Invasive Technologies: A Review

  2022cited by this paper
• Long-term Continuous Glucose Monitor Use in Very Young Children With Type 1 Diabetes: One-Year Results From the SENCE Study

  2022cited by this paper
• The effect of do‐it‐yourself real‐time continuous glucose monitoring on psychological and glycemic variables in children with type 1 diabetes: A randomized crossover trial

  2022cited by this paper
• Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes

  2022cited by this paper
• Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study.

  2022cited by this paper
• Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin

  2022influential reference
• Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pediatric Registry SWEET

  2021cited by this paper
• A decade of improved glycemic control in young children with type 1 diabetes: A population‐based cohort study

  2021cited by this paper
• Cost considerations for adoption of diabetes technology are pervasive: A qualitative study of persons living with type 1 diabetes and their families

  2021cited by this paper
• CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study.

  2021cited by this paper
• Universal Subsidized Continuous Glucose Monitoring Funding for Young People With Type 1 Diabetes: Uptake and Outcomes Over 2 Years, a Population-Based Study.

  2021cited by this paper
• Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real‐world cohort study

  2021cited by this paper
• Does introduction of continuous glucose monitoring at diagnosis of type 1 diabetes increase uptake in children and adolescents?

  2021cited by this paper
• Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study

  2021cited by this paper
• A Review of Non-Invasive Optical Systems for Continuous Blood Glucose Monitoring

  2021cited by this paper
• Real-Time Continuous Glucose Monitoring Benefits Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes Irrespective of Insulin Delivery Modality: Subanalysis of the MILLENNIAL Study

  2021cited by this paper
• Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study

  2021cited by this paper
• Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study

  2021cited by this paper
• Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study §

  2021cited by this paper
• 616-P: CGM Use and A1C: A Transatlantic Comparison of the DPV Initiative and T1D Exchange Quality Improvement Collaborative (T1DX-QI)

  2021cited by this paper
• Multicenter Evaluation Study Comparing a New Factory-Calibrated Real-Time Continuous Glucose Monitoring System to Existing Flash Glucose Monitoring System

  2021cited by this paper
• Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes

  2021cited by this paper
• Assessment of metabolic control and use of flash glucose monitoring systems in a cohort of pediatric, adolescents, and adults patients with Type 1 diabetes

  2021cited by this paper
• Diabetes distress and glycaemic control in young adults with type 1 diabetes: Associations by use of insulin pumps and continuous glucose monitors

  2021cited by this paper
• Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes

  2021cited by this paper
• Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.

  2021cited by this paper
• Blood glucose monitoring (BGM) still matters for many: Associations of BGM frequency and glycemic control in youth with type 1 diabetes.

  2021cited by this paper
• Beyond A1C: A Practical Approach to Interpreting and Optimizing Continuous Glucose Data in Youth

  2021cited by this paper
• Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices

  2021cited by this paper
• Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA1c in a Multiethnic Cohort of Adolescents and Young Adults With Type 1 Diabetes: The MILLENNIALS Study

  2020cited by this paper
• Novel Glucose Sensing Technology And Hypoglycaemia In Type

  2020cited by this paper
• Reduction in Diabetic Ketoacidosis and Severe Hypoglycemia in Pediatric Type 1 Diabetes During the First Year of Continuous Glucose Monitoring: A Multicenter Analysis of 3,553 Subjects From the DPV Registry

  2020cited by this paper
• HbA1c: The Glucose Management Indicator, Time in Range, and Standardization of Continuous Glucose Monitoring Reports in Clinical Practice.

  2020cited by this paper
• Use of Diabetes Technology in Children: Role of Structured Education for Young People with Diabetes and Families.

  2020cited by this paper
• Prevalence and Prevention of Contact Dermatitis Caused by FreeStyle Libre: A Monocentric Experience

  2020cited by this paper
• Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets

  2020cited by this paper
• Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain

  2020cited by this paper
• Adverse cutaneous reaction to diabetic glucose sensors and insulin pumps: Irritant contact dermatitis or allergic contact dermatitis?

  2020influential reference
• Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials

  2020cited by this paper
• Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus

  2020cited by this paper
• A Three-Way Accuracy Comparison of the Dexcom G5, Abbott Freestyle Libre Pro, and Senseonics Eversense Continuous Glucose Monitoring Devices in a Home-Use Study of Subjects with Type 1 Diabetes

  2020cited by this paper
• Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.

  2020cited by this paper
• Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit

  2020cited by this paper
• Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance

  2020cited by this paper
• Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring‐derived glycemic makers in children and adolescents with type 1 diabetes

  2020cited by this paper
• High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey

  2020cited by this paper
• Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials

  2020cited by this paper
• Effect of 6 months flash glucose monitoring in youth with type 1 diabetes and high-risk glycemic control – a randomized controlled trial

  2020cited by this paper
• Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial

  2020cited by this paper
• Effect of Repeated Doses of Acetaminophen on a Continuous Glucose Monitoring System with Permselective Membrane

  2020cited by this paper
• Long‐term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration

  2020cited by this paper

• International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring.

  2026cites this paper
• Flash glucose monitoring in children under 4 years of age: a prospective evaluation of the Freestyle Libre 2 in a pediatric type 1 diabetes population

  2026cites this paper
• Budget Impact of Advanced Insulin Delivery Systems for the Management of Type 1 Diabetes

  2026cites this paper
• Childhood Diabetes

  2026cites this paper
• Impact of continuous glucose monitoring on fear of hypoglycemia and quality of life in children and adolescents with type 1 diabetes

  2026cites this paper
• Barriers and Opportunities for Diabetes Medical Management Plan (DMMP) Implementation in Schools: A National Survey of School Nurses and Diabetes Providers.

  2025cites this paper
• Health Technology Assessment of Continuous Glucose Monitoring Systems for Paediatric Patients

  2025cites this paper
• Team Based Pediatric Type 1 Diabetes Care in the US: Current Practices and Sustainability Concerns.

  2025cites this paper
• Comment on “Feasibility of continuous glucose monitoring in children with diabetic ketoacidosis”

  2025cites this paper
• Continuous glucose monitoring in Korean pediatric patients with type 1 diabetes: current landscape and clinical implications

  2025cites this paper
• Swiss Diabetes and Technology recommendations.

  2025cites this paper
• Smart health monitoring: an interactive Raspberry Pi-based system for managing diabetes and hypertension in children

  2025cites this paper
• Development and Methodology of the 2024 and 2026 ISPAD Clinical Practice Guidelines.

  2025cites this paper
• Can Glucose Alarm Fatigue Threaten the Absolute Clinical Benefit of Continuous Glucose Monitoring in Optimal Glucose Management in Children and Adolescents with Type 1 Diabetes? A Narrative Review

  2025cites this paper
• Beyond Access: Racial and Socioeconomic Disparities in Device Use Among Youth with Type 1 Diabetes

  2025cites this paper
• Artificial intelligence methods in gestational diabetes mellitus prediction: A systematic literature review

  2025cites this paper
• Stigma in Adolescents With Type 1 Diabetes: Consequences and the Moderating Role of IntentionalSelf‐Regulation

  2025influential citation
• Glycemic Control in Children and Adolescents with Type 1 Diabetes: From Challenges to Innovation

  2025cites this paper
• Disparities in Time to Technology Initiation in the Year Following Diagnosis of Type 1 Diabetes among Youth: A Retrospective Cohort Study.

  2025cites this paper
• Sustained HbA1c Improvements Over 36 Months in Youth in the Teamwork, Targets, Technology, and Tight Control (4T) Study.

  2025cites this paper
• International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies – Insulin Delivery

  2024cites this paper
• REVIEW ARTICLE Type 2 diabetes mellitus and recent treatment options in adolescents and young adults

  year unknowncites this paper